GlassScriptPhysician profile
Kelly Walker
NPI 1659761054
$1,224.46
in general payments reported to CMS, 2019-2025
20 companies · $109 in 2025
The $109 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $106 · 2022: $127 · 2023: $340 · 2024: $543 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $991.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $991.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $441.40 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Dexcom, INC. | $130.85 | 2023-2024 | Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Pfizer INC. | $83.67 | 2023-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $69.91 | 2022-2023 | Gattex, Trintellix |
| Otsuka America Pharmaceutical, INC. | $63.22 | 2023-2024 | Rexulti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $60.76 | 2023-2024 | Jardiance, Tradjenta, Ofev |
| Merck Sharp & Dohme LLC | $56.34 | 2023-2024 | Gardasil 9, Gardasil, Capvaxive |
| Astrazeneca Pharmaceuticals LP | $44.22 | 2023-2024 | Farxiga |
| Exact Sciences Corporation | $35.90 | 2024 | Cologuard Collection Kit |
| Lilly USA, LLC | $33.39 | 2022-2024 | Zepbound, Mounjaro |
| Mylan Specialty L.P. | $28.23 | 2024 | Yupelri |
| Lundbeck LLC | $26.29 | 2024 | Rexulti |
| Abbvie INC. | $24.07 | 2022 | |
| Sunovion Pharmaceuticals INC. | $20.45 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $19.06 | 2024 | Caplyta |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $18.80 | 2023 | Nexletol |
| Bioventus LLC | $18.50 | 2021 | |
| Amgen INC. | $18.27 | 2024 | Prolia, Evenity |
| Janssen Pharmaceuticals, INC | $15.90 | 2024 | Spravato |
| Abbott Laboratories | $15.23 | 2024 | Freestyle Libre 3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelly Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.